Sedalis sedi-lab en es it fr

Sedalis sedi-lab Brand names, Sedalis sedi-lab Analogs

Sedalis sedi-lab Brand Names Mixture

  • No information avaliable

Sedalis sedi-lab Chemical_Formula

C16H13Cl3N2OS

Sedalis sedi-lab RX_link

http://www.rxlist.com/cgi/generic3/tioconaz.htm

Sedalis sedi-lab fda sheet

Sedalis_sedi-lab FDA

Sedalis sedi-lab msds (material safety sheet)

Sedalis sedi-lab Synthesis Reference

No information avaliable

Sedalis sedi-lab Molecular Weight

387.711 g/mol

Sedalis sedi-lab Melting Point

No information avaliable

Sedalis sedi-lab H2O Solubility

No information avaliable

Sedalis sedi-lab State

Solid

Sedalis sedi-lab LogP

4.971

Sedalis sedi-lab Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Sedalis sedi-lab Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Sedalis sedi-lab Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Sedalis sedi-lab Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Sedalis sedi-lab side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Sedalis sedi-lab Patient Information

Sedalis sedi-lab Organisms Affected

Yeast and other fungi